CD,Alternative Name
CD1d,CD1.1; CD1.2; Ly-38
CD2,LFA-2; Ly-37; Ly37
CD3γ,CD3γ; CD3 γ chain; T3γ
CD3δ,CD3δ; CD3 δ chain; T3δ
CD3ε,CD3ε; CD3 ε chain; CD3; T3ε
CD4,L3T4; Ly-4
CD5,Ly-1; Lyt-1; Ly-12; Ly-A
CD5.1,Ly-1.1
CD6,T12
CD7,gp40
CD8a,Ly-2; Lyt-2; Ly-B; Ly-35
CD8b,Ly-3; Lyt-3; Ly-C; CD8b1
CD8b.2,Ly-3.2; Lyt-3.2
CD9,Tspan29
CD10,CALLA; MME; NEP
CD11a,Ly-15; Ly-21; Integrin αL
CD11b,Integrin αM; Ly-40; CR3; CR3A; MAC1
CD11c,ITGAx [Integrin αx]; CR4 [complement recep- tor-4]; iC3b receptor; Leu M5; p150;95; CD18/ CD11c
CD13,Aminopeptidase N; gp150
CD14,Mo2; LPS Receptor
CD15,SSEA-1; FAL; Lewis x
CD16,FcgRIII; Fc gRIIIa; Ly-17; FCGR3; IGFR3
CD18,Integrin β2
CD19,B4
CD20,Ly-44; B1
CD21,CR2/CR1
CD22.2,Lyb-8.2; Siglec-2
CD23,FceRII; Ly-42
CD24,Heat Stable Antigen; Ly-52; Nectadrin
CD25,Ly-43; IL-2 Receptor α chain; p55
CD26,Dipeptidyl peptidase; DPP IV; THAM
CD27,T14; s152; tnfrs7; Tp55
CD28,T90/44 antigen or Tp44
CD29,Integrin β1; VLAb; gpIIa
CD30,Ki-1
CD31,PECAM-1; gpIIa; endoCAM; platelet endothe- lial cell adhesion molecule; PECA1
CD32,FcgRII; Ly-17; Ly-m20; Fc-γ receptor 2; Low affinity immunoglobulin γ Fc receptor II
CD33,gp67; SIGLEC-3; Sialic acid-binding Ig-like lectin 3; myeloid cell surface antigen CD33
CD34,Mucosialin
CD35,CR1; C3b receptor
CD36,Scavenger receptor; FAT; GPIV; Scarb3
CD37,gp52-40; Leukocyte antigen CD37; Tet- raspanin-26; TSPAN26
CD38,ADP-ribosyl cyclase; T10; Cyclic ADP-ribose hydrolase 1
CD39,NTPDase-1; Ectonucleoside triphosphate diphosphohydrolase 1 (ENTPD1); ATPdehy- drogenase; NTPdehydrogenase-1
CD40,gp39 receptor; Bp50; MGC9013; TNFRSF5; Tumor necrosis factor receptor superfamily member 5
CD41,GPIIb; Integrin αIIb; Platelet membrane glycoprotein IIb; ITGA2B; Integrin α2b; Human Platelet Antigen-3 (HPA-3)
CD42a,GPIX; GP9; Platelet glycoprotein IX
CD42b,GPIbα; Platelet glycoprotein Ib α
CD42c,GPIbβ; Platelet glycoprotein Ib β
CD42d,GPV; Platelet glycoprotein V
CD43,Ly-48; Sialophorin; Leukosialin; Galactoglyco- protein; SPN
CD44,Ly-24; ECMRII; H-CAM; Pgp-1; Phagocytic glycoprotein I; Extracellular matrix receptor III; GP90 lymphocyte homing/adhesion receptor; Hyaluronate receptor
CD45,Leukocyte Common Antigen (LCA)
CD45.1,Ly-5.1; Ly-5a; PTPRCa
CD45.2,Ly-5.2; Ly-5b; PTPRCb
CD45R,B220; Ly-5; Lyt-4; T200; Protein tyrosine phosphatase receptor type C (PTPRC)
CD45RA,
CD45RB,
CD45RC,Protein tyrosine phosphatase receptor type C (PTPRC)
CD45RO,
CD46,Membrane Cofactor Protein (MCP); Tropho- blast leukocyte common antigen; TRA2.10
CD47,Integrin-associated protein (IAP); OA3; Neuro- philin; MER6; gp42
CD48,Blast-1; Hulym3; BCM-1; OX-45; MEM-102
CD49a,VLA-1α; Integrin α1
CD49b,VLA-2α; Integrin α2; gPIa
CD49c,VLA-3α; Integrin α3; GAPB3; Galactoprotein B3; MSK18; Very Common Antigen-2 (VCA-2)
CD49d,VLA-4α; Integrin α4
CD49e,VLA-5α; Integrin α5; Fibronectin receptor
CD49f,VLA-6α; Integrin α6; gpI
CD51,Integrin αv; VNR-α; Vitronectin-Rα
CD52,CAMPATH-1; HE5; Epididymal secretory protein E52; CLS1; MB7; B7
CD53,MOX44; TSPAN25; Tetraspanin-25
CD54,ICAM-1; Ly-47; MALA-2
CD55,Decay accelerating factor (DAF); complement- glycosylphosphatidylinositol; Cromer blood group; Daf-GPI; Daf1; GPI-DAF
CD56,Leu-19; NKH-1; Neural Cell Adhesion Molecule (NCAM)
CD59,1F5Ag; H19; protectin; MACIF; MIRL; P-18
CD61,GP IIIa; Integrin β3
CD62E,E-Selectin; ELAM-1; LECAM-2
CD62L,L-Selectin; LECAM-1; Lnhr; Ly-22; Ly-m22; Lyam-1; Lyam1
CD62P,P-Selectin; GMP-140; PADGEM
CD63,"LIMP; MLA1; gp55; NGA; LAMP-3; ME491;
OMA81H; TSPAN30; granulophysin; melanoma 1 antigen"
CD64,FcγRI; Fc-γ receptor 1; High affinity immuno- globulin γ Fc receptor I; FcγRIA
CD66a,BGP; CEA-1
CD66b,CGM6; CEA-3
CD68,Macrosiali lysosomal glycoprotein 110
CD69,Very Early Activation Antigen
CD70,CD27 Ligand
CD71,Transferrin Receptor
CD72,Lyb-2; Ly-m19
CD73,NT; Ecto-5’-nucleotidase
CD74,Ia-associated invariant chain (Ii)
CD77,Pk blood group antigen; BLA; CTH; Gb3; α-1;4- Galactosyltransferase; Gb3 synthase; A4galt
CD79a,Iga; mb-1; Ly-54
CD79b,Igb; B29
CD80,B7/BB1; B7-1; Ly-53
CD81,TAPA-1
CD82,C33 Ag; KAI1
CD83,HB15
CD84,GR6
CD86,B7-2; B70; Ly-58
CD87,uPA Receptor
CD88,C5a Ligand; C5aR
CD90,Thy-1; q; T25
CD90.1,Thy-1.1; q-AKR
CD90.2,Thy-1.2; q-C3H
CD90.2,LRP; A2MR; AI316852; α 2-Macroglobulin receptor
CD93,AA4.1; C1qRp
CD94,KP43; klrd1
CD95,Fas; APO-1
CD96,Tactile
CD97,TM7LN1; TM7S
CD98,4F2; Ly-10; RL-388
CD99,Paired immunoglobin-like type 2 receptor- ligand
CD100,Semaphorin H; coll-4; Semaphorin 4D; Sema 4D
CD101,IGSF2; V7
CD102,ICAM-2; Ly-60
CD103,Integrin aIEL
CD104,Integrin β4
CD105,Endoglin
CD106,VCAM-1
CD107a,LAMP-1
CD107b,LAMP-2; LGP-96; LAMP-B
CD108,Sema7a
CD110,Thrombopoietin; Receptor; c-mpl
CD111,PRR1; Nectin-1; CD111; CLPED1; ED4; HIgR; HVEC; MGC142031; MGC16207; OFC7; PRR; PVRR; PVRR1; SK-12
CD112,PRR2; Nectin-2; PVRL2; HVEB; MPH; Pvr; Pvs; CD112; AI325026; AI987993; Nectin-2; Pvrl2
CD113,PVRL3; Nectin-3
CD114,G-CSF Receptor; CSF3R; HG-CSFR; Granulocyte colony-stimulating factor receptor; G-CSFR
CD115,M-CSF Receptor; CSF-1R; c-fms; Fim-2
CD116,GM-CSF Receptor α chain
CD117,c-kit; Steel factor receptor; Dominant white spotting
CD118,IFN-α/β Receptor; Type I IFN-R; IFN-α Receptor
CD119,IFN-γ Receptor α chain
CD120a,TNFR1; TNF-R55
CD120b,TNFR2; TNF-R75
CD121a,IL-1 Receptor; Type I
CD121b,IL-1 Receptor; Type II
CD122,IL-2 and IL-15 Receptor b chain
CD123,IL-3 Receptor α chain
CD124,IL-4 Receptor α chain
CD125,IL-5 Receptor α chain
CD126,IL-6 Receptor α chain
CD127,IL-7 Receptor α chain
CD130,gp130; Common β chain
CD131,AIC2A and AIC2B; bIL-2 and bc
CD132,Common γ chain
CD133,AC133; Prominin-1 (PROM1)
CD134,Ly-70; OX-40 antigen; ACT35 antigen
CD135,Flk-2; Flt3; Ly-72
CD136,STK; Mst1r; RON; MSP Receptor
CD137,4-1BB; Ly-63; Tnfrsf9
CD138,Syndecan-1; Sdc1
CD140a,PDGF Receptor α chain; PDGFR-α
CD140b,PDGF Receptor β chain; PDGFR-β
CD141,Thrombomodulin; TM
CD142,Tissue Factor; Coagulation Factor III
CD143,Angiotensin converting enzyme; Dipeptidyl peptidase; ACE
CD144,VE-Cadherin; Cdh5; 7B4; VECD
CD146,MUC18; S-endo; Mcam
CD147,Basigin; HT7; Neurothelin; gp42; Neurothelin
CD148,PTPb2; ByP; Scc-1; RPTPJ
CD150,IPO-3; ESTM51; Slam
CD151,SFA-1; PETA-3; Tspan24
CD152,CTLA-4; Ly-56
CD153,CD30 Ligand
CD154,"gp39; CD40 Ligand; Ly-62; HIGM1; IMD3;
T-BAM; Tnfsf5"
CD155,Polio virus receptor (pvr); Tage4
CD156a,MS2; ADAM 8
CD156b,TACE; ADAM17
CD156c,ADAM10; Kuz; Kubanian; Madm
CD157,Ly-65; BP-3; BST-1
CD159a,NKG2A; NKG2B
CD159c,NKG2C; KLRC2
CD160,BY55
CD161a,NKR-P1A; Ly55a
CD161b,NKR-P1B; Ly55b; Ly55d
CD161c,NKR-P1C; NK-1.1; Ly-55c; Ly-59
CD162,P-Selectin glycoprotein ligand (PSGL-1); P-Selectin-IgG fusion protein
CD163,Scavenger receptor cysteine-rich type 1 protein M130
CD164,MGC-24; A115; A24
CD166,ALCAM; BEN; DM-Grasp; MuSC; SC1
CD167a,Cak; Nep; Ddr1
CD168,RHAMM; Hmmr
CD169,Sialoadhesin; Siglec-1; Sn
CD170,Siglec-5; Siglecf; Siglec9
CD171,L1; L1-NCAM; NCAM-L1; L1cam
CD172a,SIRPa; SHPS-1; BIT; P84 Antigen; SIRP; SHP-1; Ptpns1; AI835480
CD172b,SIRPb1; 9930027N05Rik; Sirpb1a
CD176,TF;HP; Tfn; hpx; AI266983; MGC102653; Trf
CD177,NB1; Pdp3; 1190003K14Rik
CD178,CD95L; Fas Ligand; Tnfsf6; APT1LG1
CD178.1,mFasL.1
CD179a,VpreB; MGC151428; Vpreb1
CD179b,l5
CD180,RP105; Ly-78; F630107B15
CD181,CXCR1; IL8Ra
CD182,CXCR2; IL8Rb; CDw128; Cmkar2; Gpcr16
CD183,CXCR3; Cmkar3; gpr9
CD184,CXCR4; Cmkar4; Fusin/LESTR
CD185,CXCR5; BLR1; Gpcr6
CD186,CXCR6; BONZO; STRL33; BB217514
CD191,CCR1; MIP-1aR; Cmkbr1
CD192,CCR2; Ckr2; Ccr2a; Ccr2b; Ckr2a; Ckr2b; mJe-r; Cmkbr2; Cc-ckr-2
CD193,CCR3; MIP-1aRL2; CKR3; Cmkbr3; CC-CKR3; Cmkbr1l2; MGC124265; MGC124266; Ccr3
CD195,CCR5; Cmkbr5; AM4-7
CD196,CCR6; KY411; Cmkbr6; CC-CKR-6
CD197,CCR7; EBI-1; BLR2; CMKBR7
CDw198,CCR8; TER1; CC-CKR-8; CKRL1; CMKBR8; CMKBRL2; CY6; GPRCY6; MGC129966; MGC129973
CDw199,CCR9; CMKBR10; GPR-9-6; A130091K22Rik
CD200,OX-2; Mox2
CD201,CCD41; EPCR; Protein C Receptor; Ccca; AI325044; Procr
CD202,Endothelial-specific receptor tyrosine kinase; Tie2; Tek; Hyk; CD202b; RP23-345A23.1; AA517024
CD203c,"Ly-41; PC-1; E-NPP1; Pca; ttw; twy; M6S1;
NPP1; Npps"
CD204,Macrophage scavenger receptor; MSR1; Scvr; SR-AII; Scara1
CD205,DEC-205; Ly-75
CD206,Mannose receptor C type-1 (MRC1); MMR; CLEC13D
CD207,Langerin; C-type lectin domain family 4 mem- ber K (CLEC4K)
CD208,LAMP3; DC-LAMP; LAMP; TSC403; 1200002D17Rik
CD209a,"DC-SIGN; CDSIGN; CIRE; CD209 antigen-like
protein A (CD209a); CLEC4L)"
CDw210a,IL-10RA ; IL-10R1
CDw210b,IL-10RB; IL-10R2
CD212,IL-12β1; IL-12β; CD212b1
CD213a1,IL-13Rα1; NR4
CD213a2,IL-13Rα2; Interleukin-13-binding protein (IL13BP)
CD217,Interleukin 17 receptor A (IL-17RA); IL-17R; CDw217
CD218a,"IL-18R1) IL-18RA; IL-18Rα; IL1 receptor-
related protein (IL-1Rrp); IL-R5"
CD218b,IL-18Rβ; IL-18 receptor accessory protein (IL- 18RAP; IL-18RAcP); IL-1R accessory protein- like (IL-1RAcPL); IL-1R7; CDw218b
CD220,Insulin receptor (INSR); IR
CD221,Insulin-like growth factor 1 receptor (IGF1R); IGF-1R; type I IGF receptor (IGF-IR); JTK13
CD222,"Cation-independent mannose-6-phosphate receptor (M6P-R; CIM6PR; CIMPR; CI-MPR);
Insulin-like growth factor 2 receptor (IGF2R; IGFIIR; IGF-IIR); MPR1; MPRI"
CD223,Lymphocyte activation gene 3 (LAG3; LAG-3); FDC protein; Ly-66
CD224,γ-glutamyltransferase 1 (GGT1); γ-glutamyl transpeptidase 1 (GGTP); GGT; GTG; EC2.3.2.2
CD225,Interferon-induced transmembrane protein 1 (IFITM1); IFI17; Interferon-inducible protein 9-27 (9-27); Leu13; Fragilis2
CD226,DNAX accessory molecule 1 (DNAM-1); Platelet and T cell activation antigen 1 (PTA-1); T lineage-specific activation antigen 1 antigen (TLiSA1)
CD227,Mucin 1 (MUC1; MUC-1); DF3 antigen; H23 antigen; PUM; PEM; EMA; Tumor-associated mucin; Episialin
CD228,Melanotransferrin (MT; MTF1); p97 Melanoma antigen (p97; MAP97); Mfi2; gp95
CD229,Lymphocyte antigen 9 (Ly9); T-Lymphocyte surface antigen Ly-9; SLAMF3; Lgp100; T100
CD229.1,Lgp-100; Ly-9.1
CD230,Prion Protein (PrP; PRNP); Major prion protein; prP27-30; prP33-35C; PrPc
CD231,Tetraspanin 7 (TSPAN7); T-cell acute lym- phoblastic leukemia-associated antigen 1 (TALLA-1); TM4SF2; Membrane component X chromosome surface marker-1 (MXS1); A15
CD232,Plexin C1 (PLXNC1); Virus-encoded semapho- rin protein receptor (VESPR; VESP-R)
CD233,Solute carrier family 4 anion exchanger member 1 (SLC4A1); Band 3; Anion exchanger 1 (AE1); Diego blood group; EPB3
CD234,Duffy antigen/chemokine receptor (DARC); Dfy; FY; Fy-glycoprotein; Glycoprotein D
CD235a,Glycophorin A (GYPA); Sialoglycoprotein α; Sialoglycoprotein A; MNS blood group antigen; PAS-2
CD236R,Glycophorin C (GYPC); Gerbich blood group antigen
CD238,Kell blood group glycoprotein (Kel); endothe- lin-3-converting enzyme (ECE3)
CD239,Basal cell adhesion molecule (BCAM; B-CAM); Lutheran blood group glycoprotein; Lu
CD240,Rh blood group system; CD240D (Rh30D; D blood antigen)
CD241,RHAG; Rh50; Rh-associated glycoprotein
CD242,ICAM-4; LW blood group
CD243,P-gp; Pgy1; Mdr1; Abcb1
CD244,2B4; C9.1; Ly90; NAIL; Nmrk; NKR2B4; SLAMF4
CD246,Alk
CD247,CD3ζ; CD3 ζ chain
CD248,TEM1; Endosialin
CD249,APA; Bp-1/6C3; Ly-51; Ly51
CD252,OX-40 Ligand; gp34; TNFSF4
CD253,"TRAIL; APO-2L; TL2; Ly81; Trail; APO-2L;
Tnfsf10"
CD254,ODF; OPG; OPGL; RANKL; Trance; Tnfsf11
CD256,APRIL; TALL2; TRDL1; Tnfsf13
CD257,BLyS; BAFF; TALL-1; TNFSF13B; TNFSF20
CD258,LTg; HVEML; LIGHT; TR2; HVEM-L; Tnfsf14
CD261,"APO2; CD261; DR4; MGC9365; TRAILR-1;
TRAILR1 Tnfrsf10a"
CD262,TRAIL-R2; Apo2; DR5; TRICK2; KILLER
CD265,RANK; TRANCE-R; ODFR; Tnfrsf11a
CD266,TWEAK Receptor; Fn14; Tnfrsf12a
CD267,TACI; Tnfrsf13b
CD268,BAFFR; Tnfrsf13c
CD269,BCMA; BCM; Tnfrsf17
CD271,"NGFR; Bex3; Ngfrap1p75; LNGFR; p75NTR;
p75NGFR; Tnfrsf16"
CD272,BTLA; B- and T Lymphocytes; MGC124217; MGC124218; A630002H24
CD273,B7DC; PD-L2; Btdc; PD-L2; MGC124039; MGC124040; F730015O22Rik; Pdcd1lg2
CD274,"B7-H1; PD-L1; Pdcd1l1; Pdcd1lg1; A530045L-
16Rik"
CD275,"B7-H2; GL50; B7RP-1; B7h; GI50; LICOS; B7RP-1; GL50-B; ICOS-L; Icoslg; Ly115l; AU044799; BG071784; KIAA0653;
mKIAA0653; Icosl"
CD276,B7h3; B7RP-2; AU016588; 6030411F23Rik
CD278,ICOS; Ly115; H4; AILIM
CD279,PD-1; Programmed death-1; Pdc1; Ly101
CD280,ENDO180; MRC2; UPARAP; MGC141530; mKIAA0709
CD281,TLR1
CD282,TLR2; Ly105
CD283,TLR3; AI957183
CD284,TLR4; Ly87; Ran/M1; Rasl2-8
CD286,TLR6
CD288,TLR8
CD289,TLR9
CD292,BMPR1A; ALK3; SKR5; ALK3; Bmpr; AU045487; 1110037I22Rik
CDw293,BMPR1B; ALK6; SKR6; Acvrlk6; CFK-43a; AI385617; AV355320
CD294,CRTH2; GPR44; Grp45; MGC130436
CD295,LeptinR; LEPR; db; Obr; obl; Modb1; LEPROT; OB-RGRP; MGC105189; obese-like
CD296,ART1; RT6; ART2; ADPRT; Yac-1
CD297,ART4; Dombrock blood group; DO; DOK1; 4432404K01Rik
CD298,Na+/K+-ATPase b3 subunit; AA409958; AI664000; AW212096; Atp1b3
CD301a,Clec10a; Mgl; Mgl1
CD302,Clec13A; DCL-1
CD304,BDCA4; Neuropilin 1; NP-1
CD305,LAIR1
CD307,Fcrl5 Fc receptor-like 5; Fcrh3; mBXMH2; Fcrl5
CD309,VEGFR2; Flk-1; KDR
CD314,NKG2D; KLRK1
CD315,CD9P1
CD316,EWI2; PGRL; KASP
CD317,BST2
CD318,CDCP1
CD319,CRACC; SLAMF7
CD320,Transcobalamin receptor
CD321,JAM1; F11 receptor; KAR
CD322,JAM2; VE-JAM
CD324,E-Cadherin; Uvomorulin
CD325,N-Cadherin; Cadherin-2
CD326,Ep-CAM; Ly-74
CD329,siglec9
CD331,FGFR1; FLT2; N-SAM
CD332,FGFR2; KGFR; KSAM
CD333,FGFR3; ACH; CEK2
CD334,FGFR4; TKF
CD335,NKp46; Ly-94
CD338,ABCG2; Mxr; ABC15; BCRP1
CD339,Jagged-1; Serrate1
CD340,c-erbB2; HER2; Neu
CD344,FZD4; Frizzled homolog 4
CD349,FZD9; Frizzled homolog 9
CD350,FZD10; Frizzled homolog 10
CD351,FCAMR; Fc receptor; IgA; IgM; high affinity
CD352,Ly-108; SLAMF6
CD353,SLAMF8; BLAME
CD354,TREM1
CD355,CRTAM
CD357,TNFRSF18; Tumor necrosis factor receptor superfamily; member 18; GITR
CD358,TNFRSF21; Tumor necrosis factor receptor superfamily; member 21; DR6
CD360,IL21R
CD361,EVI2B (ectopic viral integration site 2B)
CD362,Syndecan-2; Hspg1; Synd2
CD363,S1PR1; Sphingosine-1-phosphate receptor 1; EDG-1